Signorovitch J - Search Results

1

Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis.

Li J, Sasane M, Zhao J, Horton VG, Zhang P, Ricculli ML, Zhou ZY, Signorovitch J. Li J, et al. Among authors: signorovitch j. Adv Ther. 2018 Jul;35(7):1035-1048. doi: 10.1007/s12325-018-0734-9. Epub 2018 Jun 15. Adv Ther. 2018. PMID: 29949047

2

Major molecular response during the first year of dasatinib, imatinib or nilotinib treatment for newly diagnosed chronic myeloid leukemia: a network meta-analysis.

Signorovitch J, Ayyagari R, Reichmann WM, Wu EQ, Chen L. Signorovitch J, et al. Cancer Treat Rev. 2014 Mar;40(2):285-92. doi: 10.1016/j.ctrv.2013.09.004. Epub 2013 Sep 17. Cancer Treat Rev. 2014. PMID: 24112812 Review.

3

Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: synthesis of findings from two multi-practice chart reviews in the United States.

Signorovitch JE, Vogelzang NJ, Pal SK, Lin PL, George DJ, Wong MK, Liu Z, Wang X, Culver K, Scott JA, Jonasch E. Signorovitch JE, et al. Curr Med Res Opin. 2014 Nov;30(11):2343-53. doi: 10.1185/03007995.2014.949645. Epub 2014 Aug 27. Curr Med Res Opin. 2014. PMID: 25105304

4

Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response.

Signorovitch JE, Betts KA, Yan YS, LeReun C, Sundaram M, Wu EQ, Mulani P. Signorovitch JE, et al. Br J Dermatol. 2015 Feb;172(2):504-12. doi: 10.1111/bjd.13437. Epub 2015 Jan 21. Br J Dermatol. 2015. PMID: 25288183 Review.

5

Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies.

Heng DY, Signorovitch J, Swallow E, Li N, Zhong Y, Qin P, Zhuo DY, Wang X, Park J, Stergiopoulos S, Kollmannsberger C. Heng DY, et al. Among authors: signorovitch j. PLoS One. 2014 Dec 10;9(12):e114264. doi: 10.1371/journal.pone.0114264. eCollection 2014. PLoS One. 2014. PMID: 25493562 Free PMC article. Review.

6

Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HR+/HER2- metastatic breast cancer: a retrospective chart review in community oncology practices in the US.

Xie J, Hao Y, Li N, Lin PL, Ohashi E, Koo V, Signorovitch JE, Wu EQ, Yardley DA. Xie J, et al. Among authors: signorovitch je. Curr Med Res Opin. 2015 Jun;31(6):1095-103. doi: 10.1185/03007995.2015.1021906. Epub 2015 May 13. Curr Med Res Opin. 2015. PMID: 25971725

7

Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer.

Li N, Hao Y, Xie J, Lin PL, Zhou Z, Zhong Y, Signorovitch JE, Wu EQ. Li N, et al. Among authors: signorovitch je. Curr Med Res Opin. 2015 Aug;31(8):1573-82. doi: 10.1185/03007995.2015.1062358. Curr Med Res Opin. 2015. PMID: 26074049

8

Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder.

Zhou ZY, Sun S, Chopra P, Zhong Y, Totev T, Signorovitch J. Zhou ZY, et al. Among authors: signorovitch j. J Med Econ. 2015;18(11):919-29. doi: 10.3111/13696998.2015.1061534. Epub 2015 Jul 6. J Med Econ. 2015. PMID: 26121061 Free article.

9

Comparative efficacy and safety of daclatasvir/asunaprevir versus IFN-based regimens in genotype 1b hepatitis C virus infection.

Signorovitch JE, Betts KA, Song Y, Sorg RA, Li J, Behl AS, Kalsekar A. Signorovitch JE, et al. J Comp Eff Res. 2015 Nov;4(6):593-605. doi: 10.2217/cer.15.33. Epub 2015 Jul 10. J Comp Eff Res. 2015. PMID: 26159375 Free article. Review.

10

Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart Reviews.

Pal SK, Signorovitch JE, Reichmann WM, Li N, Koo V, Liu Z, Perez JR, Vogelzang NJ. Pal SK, et al. Among authors: signorovitch je. Clin Genitourin Cancer. 2016 Apr;14(2):160-7.e3. doi: 10.1016/j.clgc.2015.11.011. Epub 2015 Nov 19. Clin Genitourin Cancer. 2016. PMID: 26707954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters